Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in HIV-1 prevention and cure trials
Laura Powell(University of Maryland, Baltimore), Deborah Persaud(Johns Hopkins University), Joseph Szewczyk(Johns Hopkins University), Eleni Nastouli(The Francis Crick Institute), Priyanka Uprety(Children's Hospital of Philadelphia), Yann Le Duff(National Institute for Biological Standards and Control), Cheryl Jennings(Rush University Medical Center), Lilly Siems, Dolly Singh(Johns Hopkins University), Chen Ya(Children's Hospital of Chongqing Medical University), Adit Dhummakupt
Cited by 19
Related Papers
Absence of Detectable HIV-1 Viremia after Treatment Cessation in an Infant
|New England Journal of Medicine|2013|581
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials—report of a consensus meeting
|The Lancet HIV|2019|206
Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083
|The Journal of Infectious Diseases|2021|132
Therapeutic Vaccination Expands and Improves the Function of the HIV-Specific Memory T-Cell Repertoire
|The Journal of Infectious Diseases|2013|57
Progressive liver, kidney, and heart degeneration in children and adults affected by TULP3 mutations
|The American Journal of Human Genetics|2022|56